Important News
Qurgen real-time updates on corporate news, industry trends and exciting events, witnessing every step of growth.
Important News
Wuxi Fuent Biotechnology Co., Ltd. was fully relocated to the Life & Health Town Industrial Park
Suzhou Qurgen Pharmaceutical Co., Ltd. was established as the China headquarters, marking the launch of the company's industrialization layout.
GLP-PK and toxicology studies in rats and dogs were completed and reported by Charles River Laboratories, a renowned US preclinical CRO company, demonstrating that QQ-SON was well tolerated with no adverse reactions.
Qurgen announced that the Company had successfully completed its Series A financing totaling US$12 million between October 2017 and May 2019.